Nuclear Medicine

What is Nuclear Medicine?

Nuclear medicine is a specialised field within medical imaging that uses minute quantities of radioactive substances, known as radiopharmaceuticals, to assess organ function and structure. This technique provides a unique window into the body's physiological processes at a molecular level, supporting both the diagnosis and treatment of a wide range of diseases.

Radiopharmaceuticals are designed to target specific organs or tissues based on their unique chemical properties. Once administered, typically through intravenous injection, these substances emit gamma rays, a form of radiation that can be detected by specialised imaging devices such as a gamma camera or a positron emission tomography (PET) scanner. The resulting images show the distribution and uptake of the radiopharmaceutical within the body, revealing how well a particular organ or tissue is functioning.

Understanding Nuclear Medicine

Unlike conventional imaging techniques, which mainly capture the structure or anatomy of the body, nuclear medicine is distinctive in its ability to reveal how an organ or tissue is functioning at a molecular level. This makes it particularly valuable for detecting disease at an early stage, sometimes before structural changes become evident on other forms of imaging.

Beyond its diagnostic capabilities, nuclear medicine also offers targeted therapeutic interventions. Radiopharmaceuticals can be used to deliver therapeutic doses of radiation directly to diseased tissue, minimising damage to surrounding healthy structures. This dual diagnostic and therapeutic capability, sometimes referred to as theranostics, is particularly valuable in the treatment of certain cancers and thyroid conditions.

Diagnostic Applications of Nuclear Medicine

Nuclear medicine plays a role in the diagnosis of a broad spectrum of medical conditions across several fields:

• Oncology: Identifying and staging various cancers, as well as monitoring how well a cancer is responding to treatment.
• Cardiology: Evaluating cardiac function and myocardial perfusion, and detecting coronary artery disease.
• Endocrinology: Assessing thyroid function and identifying thyroid nodules.
• Neurology: Supporting the diagnosis of neurological disorders such as Alzheimer's disease and Parkinson's disease.
• Nephrology: Evaluating kidney function and detecting kidney abnormalities.

Common Nuclear Medicine Tests and Therapies

Nuclear medicine encompasses both diagnostic imaging tests and targeted radiotherapy treatments, including:

• Full Body PET-CT Bone with F18-Sodium Fluoride: Shows how well bones are functioning, helping detect disease before it becomes evident on other imaging tests.
• Full Body PET-CT with GA68-PSMA: Offers high sensitivity and specificity in detecting prostate cancer cells in regional lymph nodes, identifying both primary and metastatic disease.
• Cardiac Nuclear Stress Test: Shows how blood is pumped to the heart during exercise and at rest, helping to assess cardiac function and detect coronary artery disease.
• Selective Internal Radiation Therapy (SIRT) for Liver Tumors: Delivers targeted, tumour-destroying doses of radiation directly to cancerous cells in the liver while sparing healthy liver tissue.
• Iodine-131 Therapy: A form of radioiodine used to treat thyroid conditions such as hyperthyroidism and thyroid cancer.
• Actinium-225 PSMA Nuclear Therapy: A targeted therapy for advanced prostate cancer, particularly for patients who have already been heavily treated with other forms of cancer therapy.

In addition to its diagnostic capabilities, nuclear medicine offers targeted therapeutic interventions. Radiopharmaceuticals can be employed to deliver therapeutic doses of radiation directly to diseased tissues, minimizing damage to surrounding healthy structures. This approach is particularly valuable in the treatment of certain cancers and thyroid conditions.

Conditions Supported by Nuclear Medicine

Nuclear medicine tests and therapies are used in the diagnosis and treatment of a range of conditions, including:

• Uterine cancer: Also known as endometrial cancer, one of the most common cancers of the female reproductive system, in which nuclear imaging can support staging and treatment planning.
• Testicular cancer: A cancer that begins in the testicle, most often found in men aged 15 to 44, where imaging can support diagnosis and monitoring.
• Prostate cancer: Both diagnosis, through PSMA PET-CT imaging, and treatment of advanced disease, through targeted radionuclide therapy, are supported by nuclear medicine.
• Liver tumors: Including hepatocellular carcinoma, which can be treated directly using selective internal radiation therapy.
• Thyroid conditions: Including hyperthyroidism and thyroid cancer, which can be treated using radioiodine therapy.
• Coronary artery disease: Assessed through nuclear stress testing, which shows how well blood is reaching the heart muscle during exercise and at rest.

What to Expect During a Nuclear Medicine Procedure

Most nuclear medicine procedures follow a broadly similar process, though the exact details vary depending on the specific test or therapy being performed.

• Preparation: Depending on the procedure, patients may be asked to fast, adjust certain medications, or avoid specific substances beforehand, and should inform their care team of any allergies or existing medical conditions.
• Administration of the radiopharmaceutical: The radioactive tracer or therapeutic agent is usually given by intravenous injection, though in some cases it may be swallowed or inhaled.
• Uptake time: A waiting period, ranging from minutes to several hours, allows the radiopharmaceutical to travel through the body and concentrate in the target organ or tissue.
• Imaging or treatment: For diagnostic scans, a gamma camera or PET scanner captures images over a period of time while the patient lies still. For therapeutic procedures, the radiopharmaceutical is left to act on the target tissue over a longer period.
• Post-procedure precautions: Following certain therapies, such as radioiodine treatment, patients may be advised to limit close contact with others, particularly pregnant women and young children, for a short period while the radioactivity in the body decreases.

Safety and Radiation Exposure

Understandably, many patients have questions about the safety of procedures involving radioactive materials. While nuclear medicine procedures do involve radiation exposure, the amount used is minimal and is carefully calculated to be as low as reasonably possible while still achieving a clear, diagnostically useful result or an effective therapeutic dose.

The radiopharmaceuticals used in nuclear medicine are typically cleared from the body naturally over hours to days, through normal bodily processes. For the vast majority of patients, the benefits of early, accurate diagnosis and targeted treatment far outweigh the minimal risks associated with this level of radiation exposure. Patients with specific concerns, such as pregnancy or breastfeeding, should discuss these with their care team before undergoing any nuclear medicine procedure.

For many patients, a nuclear medicine test forms one part of a broader diagnostic or treatment journey, whether confirming a diagnosis, guiding cancer staging, or delivering a targeted therapy directly to diseased tissue. Because nuclear medicine can detect disease activity at a molecular level, it often provides information that helps guide decisions about further treatment well before changes would be visible on other forms of imaging.

Our dedicated teams of experienced multidisciplinary specialists and healthcare professionals work together to provide treatment plans tailored to the needs of our patients on their recovery journey.

Speak to our Specialists today.